Mirae Asset Healthcare Fund Direct Growth
NAV: as on:
MIn SIP Amount: 500
Rating: Not Rated
Fund Size: 2560.3751
SIP Amount
₹
Frequency
SIP Start Date
Holdings
Name Sector Instrument Type Assets(%)
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 12.64
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 12.64
Sun Pharmaceutical Industries Ltd Pharmaceuticals -- 12.64
Aurobindo Pharma Ltd Pharmaceuticals -- 10.01
Aurobindo Pharma Ltd Pharmaceuticals -- 10.01
Aurobindo Pharma Ltd Pharmaceuticals -- 10.01
Cipla Ltd Pharmaceuticals -- 8.94
Cipla Ltd Pharmaceuticals -- 8.94
Cipla Ltd Pharmaceuticals -- 8.94
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 6.85
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 6.85
Dr. Reddy'S Laboratories Ltd Pharmaceuticals -- 6.85
Apollo Hospitals Enterprises Ltd Health Care -- 5.9
Apollo Hospitals Enterprises Ltd Health Care -- 5.9
Apollo Hospitals Enterprises Ltd Health Care -- 5.9
Lupin Ltd Pharmaceuticals -- 4.82
Lupin Ltd Pharmaceuticals -- 4.82
Lupin Ltd Pharmaceuticals -- 4.82
Glenmark Pharmaceuticals Ltd Pharmaceuticals -- 4.76
Glenmark Pharmaceuticals Ltd Pharmaceuticals -- 4.76
Glenmark Pharmaceuticals Ltd Pharmaceuticals -- 4.76
Divi'S Laboratories Ltd Pharmaceuticals -- 4.39
Divi'S Laboratories Ltd Pharmaceuticals -- 4.39
Divi'S Laboratories Ltd Pharmaceuticals -- 4.39
Gland Pharma Ltd Pharmaceuticals -- 4.17
Gland Pharma Ltd Pharmaceuticals -- 4.17
Gland Pharma Ltd Pharmaceuticals -- 4.17
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 3.75
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 3.75
Torrent Pharmaceuticals Ltd Pharmaceuticals -- 3.75
Krishna Institute Of Medical Sciences Ltd Health Care -- 3.73
Krishna Institute Of Medical Sciences Ltd Health Care -- 3.73
Krishna Institute Of Medical Sciences Ltd Health Care -- 3.73
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 3.46
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 3.46
JB Chemicals & Pharmaceuticals Ltd Pharmaceuticals -- 3.46
Fortis Healthcare Ltd Health Care -- 3.2
Fortis Healthcare Ltd Health Care -- 3.2
Fortis Healthcare Ltd Health Care -- 3.2
Zydus Lifesciences Ltd Pharmaceuticals -- 2.65
Zydus Lifesciences Ltd Pharmaceuticals -- 2.65
Zydus Lifesciences Ltd Pharmaceuticals -- 2.65
Syngene International Ltd Health Care -- 2.39
Syngene International Ltd Health Care -- 2.39
Syngene International Ltd Health Care -- 2.39
Max Healthcare Institute Ltd Health Care -- 2.29
Max Healthcare Institute Ltd Health Care -- 2.29
Max Healthcare Institute Ltd Health Care -- 2.29
Alkem Laboratories Ltd Pharmaceuticals -- 1.86
Alkem Laboratories Ltd Pharmaceuticals -- 1.86
Alkem Laboratories Ltd Pharmaceuticals -- 1.86
Wockhardt Ltd Pharmaceuticals -- 1.74
Wockhardt Ltd Pharmaceuticals -- 1.74
Wockhardt Ltd Pharmaceuticals -- 1.74
Ipca Laboratories Ltd Pharmaceuticals -- 1.68
Ipca Laboratories Ltd Pharmaceuticals -- 1.68
Ipca Laboratories Ltd Pharmaceuticals -- 1.68
Ajanta Pharma Ltd Pharmaceuticals -- 1.53
Ajanta Pharma Ltd Pharmaceuticals -- 1.53
Ajanta Pharma Ltd Pharmaceuticals -- 1.53
Mankind Pharma Ltd Pharmaceuticals -- 1.48
Mankind Pharma Ltd Pharmaceuticals -- 1.48
Mankind Pharma Ltd Pharmaceuticals -- 1.48
Dr. Lal Pathlabs Ltd Health Care -- 1.43
Dr. Lal Pathlabs Ltd Health Care -- 1.43
Dr. Lal Pathlabs Ltd Health Care -- 1.43
Natco Pharma Ltd Pharmaceuticals -- 1.15
Natco Pharma Ltd Pharmaceuticals -- 1.15
Natco Pharma Ltd Pharmaceuticals -- 1.15
Biocon Ltd Pharmaceuticals -- 1.08
Biocon Ltd Pharmaceuticals -- 1.08
Biocon Ltd Pharmaceuticals -- 1.08
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 1
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 1
Emcure Pharmaceuticals Ltd Pharmaceuticals -- 1
Strides Pharma Science Ltd Pharmaceuticals -- 0.74
Strides Pharma Science Ltd Pharmaceuticals -- 0.74
Strides Pharma Science Ltd Pharmaceuticals -- 0.74
Sanofi India Ltd Pharmaceuticals -- 0.69
Sanofi India Ltd Pharmaceuticals -- 0.69
Sanofi India Ltd Pharmaceuticals -- 0.69
Net Receivables / Payables Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.53
Net Receivables / Payables Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.53
Net Receivables / Payables Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.53
SRF Ltd Chemicals -- 0.52
SRF Ltd Chemicals -- 0.52
SRF Ltd Chemicals -- 0.52
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.4
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.4
Sanofi Consumer Healthcare India Ltd Pharmaceuticals & Biotechnology -- 0.4
TREPS Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.2
TREPS Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.2
TREPS Cash/Deposits/Margins/Treps/Repo/Swaps -- 0.2
Mirae Asset Liquid Fund - Direct Growth Mutual Fund Units -- 0.01
Mirae Asset Liquid Fund - Direct Growth Mutual Fund Units -- 0.01
Mirae Asset Liquid Fund - Direct Growth Mutual Fund Units -- 0.01
Laurus Labs Ltd Pharmaceuticals -- 0
Laurus Labs Ltd Pharmaceuticals -- 0
Laurus Labs Ltd Pharmaceuticals -- 0
Holding analysis
Asset Class Percentage
Equity 99.258
Debt 0
Cash
Equity sector allocation
Pharmaceuticals
Health Care
Cash/Deposits/Margins/Treps/Repo/Swaps
Chemicals
Pharmaceuticals & Biotechnology
Mutual Fund Units
238.17
56.82
2.19
1.56
1.2
0.03
Sector Holding Percentage
Pharmaceuticals 238.17
Health Care 56.82
Cash/Deposits/Margins/Treps/Repo/Swaps 2.19
Chemicals 1.56
Pharmaceuticals & Biotechnology 1.2
Mutual Fund Units 0.03
Advanced Ratios
Standard Dev. 12.856
P/E Ratio 43.5058
Sharpe -0.9885
Alpha 0.663
Beta 0.9098
Sortino 0.122
Minimum Investment Amounts
Minimum for 1st Investment 5000
Minimum for SIP 500
Returns and rankings
Category : Equity
Annualised returns
1Y 3Y 5Y
Fund returns 52.65 19.53 32.67
Category average -9.1 23.3 12.4
Rank with in category
Expense ratio:0.49

Inclusive of GST

Exit load

1% on or before 1Y(365D), Nil after 1Y(365D)

Stamp duty

0.005% (from July 1st, 2020)

Tax implication

Returns are taxed at 15%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 10% on returns of Rs 1 lakh+ in a financial year.

Fund house & investment objective
Rank (total assets) ---
Total AUM ₹1,94,565.59Cr
Date of Incorporation ---

Investment Objective

The Investment Objective Of The Scheme Is To Seek To Generate Long Term Capital Appreciation Through Investing In Equity And Equity Related Securities Of Companies Benefitting Directly Or Indirectly In Healthcare And Allied Sectors In India. The Scheme Does Not Guarantee Or Assure Any Returns.

Fund benchmark S&P BSE Health Care
Scheme Information Document(SID)
Fund house contact details
Address: Unit 606, 6th Floor, Windsor, Off CST Road, Kalina, Santacruz (E),
Mumbai - 400 098
Phone:--------
Launch Date:--------
E-mail: customercare@miraeasset.com
Website: www.miraeassetmf.co.in
Mirae Asset Investment Managers (India) Private Limited
Custodian:Deutsche Bank
Registrar & Transfer Agent:Karvy
Address: 7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
E-mail: enq_h@camsonline.com
enq_h@camsonline.com
Website: www.camsonline.com
Compare funds
Funds Comparison
Fund management
Vrijesh Kasera
Jan 2013 - Present
Education
--------------
Experience
--------------
Fund manager Also manages these schemes
Mirae Asset Healthcare Fund -Regular Growth